Literature DB >> 16333848

Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.

Yoshifumi Komoike1, Futoshi Akiyama, Yuichi Iino, Tadashi Ikeda, Sadako Akashi-Tanaka, Shozo Ohsumi, Mikihiro Kusama, Muneaki Sano, Eisei Shin, Kimito Suemasu, Hiroshi Sonoo, Tetsuya Taguchi, Tsunehiro Nishi, Reiki Nishimura, Shunsuke Haga, Keiichi Mise, Takayuki Kinoshita, Shigeru Murakami, Masataka Yoshimoto, Hideaki Tsukuma, Hideo Inaji.   

Abstract

BACKGROUND: The clinical features of ipsilateral breast tumor recurrence (IBTR) after breast conserving therapy (BCT) for early stage breast cancer were analyzed from long-term follow-up of BCT in Japan. The purpose of this study was to clarify risk factors of IBTR and the impact of IBTR on development of distant metastases in this ethnic group.
METHODS: Patients (N = 1901)with unilateral breast cancer < or = 3 cm in diameter who underwent BCT at 18 Japanese major breast cancer treatment institutes from 1986 to 1993 were registered in this study. Survival rates, the incidences of IBTR and distant metastases, and annual rates of IBTR and distant metastases after primary operation were calculated by the Kaplan-Meier method. A Cox proportional hazards model was used to estimate the risks of IBTR and distant metastases. A Cox model was also used to estimate the risks of distant metastases after IBTR in the group of IBTR.
RESULTS: At a median follow-up time of 107 months, the 10-year overall and disease-free survival rates were 83.9% and 77.8%, respectively. The 10-year cumulative rates of IBTR were 8.5% in the patients with postoperative irradiation and 17.2% in the patients without irradiation. The 10-year cumulative distant metastasis rate was 10.9%. On multivariate analysis, young age, positive surgical margin, and omission of radiation therapy were significant predictors of IBTR. In addition, IBTR significantly correlated with subsequent distant metastases (hazard ratio, 3.93; 95% confidence interval, 2.676-5.771; P < 0.0001). Among patients who developed IBTR, initial lymph node metastases and short interval to IBTR were significant risk factors for subsequent distant metastasis.
CONCLUSIONS: Young age, positive surgical margin, and omission of radiation therapy seemed to be important factors in relation to local control. The authors' results also indicated that IBTR is significantly associated with subsequent distant metastasis. Patients with positive nodal status at primary operation or with short interval from primary operation to IBTR are at especially high risk of distant metastasis. It remains unclear, however, whether IBTR is an indicator or a cause of subsequent distant metastases. Copyright 2005 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 16333848     DOI: 10.1002/cncr.21551

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  44 in total

1.  Clinical outcomes of video-assisted skin-sparing partial mastectomy for breast cancer and immediate reconstruction with latissimus dorsi muscle flap as breast-conserving therapy.

Authors:  Hiroo Nakajima; Ikuya Fujiwara; Naruhiko Mizuta; Koichi Sakaguchi; Mahiro Ohashi; Asako Nishiyama; Yoshimi Umeda; Miho Ichida; Junji Magae
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Ten-year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma.

Authors:  José Luis Guinot; M Isabel Tortajada; María Carrascosa; Vicente Crispín; Ana Otero; Belén Ríos; Eleonor Rivin; Miguel Santos; Pablo Soler; Leoncio Arribas
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

3.  Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.

Authors:  Laura L Michel; Laura Sommer; Rosa González Silos; Justo Lorenzo Bermejo; Alexandra von Au; Julia Seitz; André Hennigs; Katharina Smetanay; Michael Golatta; Jörg Heil; Florian Schütz; Christof Sohn; Andreas Schneeweiss; Frederik Marmé
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

4.  Five-year risk of interval-invasive second breast cancer.

Authors:  Janie M Lee; Diana S M Buist; Nehmat Houssami; Emily C Dowling; Elkan F Halpern; G Scott Gazelle; Constance D Lehman; Louise M Henderson; Rebecca A Hubbard
Journal:  J Natl Cancer Inst       Date:  2015-04-22       Impact factor: 13.506

Review 5.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

6.  Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy.

Authors:  Makoto Ishitobi; Mizuho Shiba; Takahiro Nakayama; Hiroki Koyama; Yasuhiro Tamaki
Journal:  Mol Clin Oncol       Date:  2015-03-30

Review 7.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

Review 8.  Breast cancer local therapy: what is its effect on mortality?

Authors:  John R Benson; Katy A T Teo
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

Review 9.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

Review 10.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.